UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
FORM 10-Q
| [X] | Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 | |
| For the period ended August 31, 2003. | ||
| [ ] | Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 | |
| For the transition period from to | ||
| Commission File Number 1-9927 |
COMPREHENSIVE CARE CORPORATION
| Delaware | 95-2594724 | |
|
|
||
| (State or other jurisdiction of incorporation or organization) |
(IRS Employer Identification No.) |
200 South Hoover Blvd, Suite 200, Tampa, FL 33609
(813) 288-4808
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes [X] No [ ]
Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).
Yes [ ] No [X]
Indicate the number of shares outstanding of each of the issuers classes of Common Stock, as of the latest practicable date:
| Classes | Outstanding at October 6, 2003 | |
|
|
||
| Common Stock, par value $.01 per share | 3,939,549 |
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
Index
| Page | ||||||||
PART I FINANCIAL INFORMATION |
||||||||
Item 1Consolidated Financial Statements |
||||||||
Consolidated Balance Sheets,
August 31, 2003 and May 31, 2003 |
3 | |||||||
Consolidated Statements of Operations for
the three months ended August 31, 2003 and 2002 |
4 | |||||||
Consolidated Statements of Cash Flows for
the three months ended August 31, 2003 and 2002 |
5 | |||||||
Notes to Consolidated Financial Statements |
6-11 | |||||||
Item 2Managements Discussion and Analysis of Financial Condition and
Results of Operations |
11-17 | |||||||
Item 3Quantitative and Qualitative Disclosures About Market Risk |
17 | |||||||
Item 4Controls and Procedures |
17-18 | |||||||
PART II OTHER INFORMATION |
||||||||
Item 1Legal Proceedings |
18 | |||||||
Item 6Exhibits and Reports on Form 8-K |
19 | |||||||
Signatures |
20 | |||||||
Certifications |
21-24 | |||||||
2
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
PART I. FINANCIAL INFORMATION
Item 1 Consolidated Financial Statements
Consolidated Balance Sheets
| August 31, | May 31, | ||||||||
| 2003 | 2003 | ||||||||
| (unaudited) | |||||||||
| (Amounts in thousands) | |||||||||
ASSETS |
|||||||||
Current assets: |
|||||||||
Cash and cash equivalents |
$ | 3,416 | $ | 3,590 | |||||
Accounts receivable, less allowance for doubtful accounts of $27 |
257 | 75 | |||||||
Accounts receivable managed care reinsurance contract |
485 | 354 | |||||||
Other current assets |
445 | 605 | |||||||
Total current assets |
4,603 | 4,624 | |||||||
Property and equipment, net |
284 | 230 | |||||||
Note receivable |
154 | 155 | |||||||
Goodwill, net |
991 | 991 | |||||||
Restricted cash |
327 | 328 | |||||||
Other assets |
46 | 51 | |||||||
Total assets |
$ | 6,405 | $ | 6,379 | |||||
LIABILITIES AND STOCKHOLDERS DEFICIT |
|||||||||
Current liabilities: |
|||||||||
Accounts payable and accrued liabilities |
$ | 2,001 | $ | 1,836 | |||||
Accrued claims payable |
4,039 | 4,103 | |||||||
Accrued reinsurance claims payable |
3,343 | 3,117 | |||||||
Income taxes payable |
17 | 15 | |||||||
Total current liabilities |
9,400 | 9,071 | |||||||
Long-term liabilities: |
|||||||||
Long-term debt |
2,244 | 2,244 | |||||||
Other liabilities |
58 | 54 | |||||||
Total long-term liabilities |
2,302 | 2,298 | |||||||
Total liabilities |
11,702 | 11,369 | |||||||
Commitments and Contingencies (Note 5) |
|||||||||
Stockholders deficit: |
|||||||||
Preferred stock, $50.00 par value; authorized 18,740 shares; none issued |
| | |||||||
Common stock, $0.01 par value; authorized 12,500,000 shares; issued
and outstanding 3,939,049 and 3,936,549 |
39 | 39 | |||||||
Additional paid-in-capital |
51,940 | 51,928 | |||||||
Deferred compensation |
(10 | ) | (16 | ) | |||||
Accumulated deficit |
(57,266 | ) | (56,941 | ) | |||||
Total stockholders deficit |
(5,297 | ) | (4,990 | ) | |||||
Total liabilities and stockholders deficit |
$ | 6,405 | $ | 6,379 | |||||
See accompanying notes.
3
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
Consolidated Statements of Operations
(Unaudited)
(Amounts in thousands, except per share amounts)
| Three months Ended | |||||||||
| August 31, | |||||||||
| 2003 | 2002 | ||||||||
Operating revenues |
$ | 7,893 | $ | 8,307 | |||||
Costs and expenses: |
|||||||||
Healthcare operating expenses |
6,852 | 7,353 | |||||||
General and administrative expenses |
908 | 888 | |||||||
Recovery of doubtful accounts |
(8 | ) | (8 | ) | |||||
Depreciation and amortization |
27 | 68 | |||||||
| 7,779 | 8,301 | ||||||||
Operating income from continuing operations before items
shown below |
114 | 6 | |||||||
Other income (expense): |
|||||||||
Gain on sale of assets |
| 3 | |||||||
Loss on disposal of assets |
| (5 | ) | ||||||
Interest income |
12 | 16 | |||||||
Interest expense |
(48 | ) | (46 | ) | |||||
Other non-operating income |
1 | | |||||||
Income (loss) from continuing operations before income taxes |
79 | (26 | ) | ||||||
Income tax expense |
17 | 7 | |||||||
Income (loss) from continuing operations |
$ | 62 | $ | (33 | ) | ||||
Loss from Discontinued Operations |
(387 | ) | | ||||||
Net loss attributable to common stockholders |
$ | (325 | ) | $ | (33 | ) | |||
Earnings (loss) per common share basic: |
|||||||||
Earnings (loss) from continuing operations |
$ | 0.02 | $ | (0.01 | ) | ||||
Loss from discontinued operations |
(0.10 | ) | | ||||||
Net loss |
$ | (0.08 | ) | $ | (0.01 | ) | |||
Earnings (loss) per common share diluted: |
|||||||||
Earnings (loss) from continuing operations |
$ | 0.01 | $ | (0.01 | ) | ||||
Loss from discontinued operations |
(0.08 | ) | | ||||||
Net loss |
$ | (0.07 | ) | $ | (0.01 | ) | |||
Weighted average common shares outstanding: |
|||||||||
Basic |
3,937 | 3,885 | |||||||
Diluted |
4,725 | 3,885 | |||||||
See accompanying notes.
4
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
Consolidated Statements of Cash Flows
(Unaudited)
| Three months ended | |||||||||
| August 31, | |||||||||
| 2003 | 2002 | ||||||||
| (Amounts in thousands) | |||||||||
Cash flows from operating activities: |
|||||||||
Net income (loss) from continuing operations |
$ | 62 | $ | (33 | ) | ||||
Adjustments to reconcile net income (loss) to net cash used in
operating activities: |
|||||||||
Depreciation and amortization |
27 | 68 | |||||||
Compensation expense stock and stock options issued |
17 | 11 | |||||||
Gain on sale of assets |
| (3 | ) | ||||||
Loss on disposal of assets |
| 5 | |||||||
Changes in assets and liabilities: |
|||||||||
Accounts receivable |
(182 | ) | (6 | ) | |||||
Accounts receivable managed care reinsurance contract |
(131 | ) | (101 | ) | |||||
Other current assets, restricted funds, and other non-current assets |
74 | (92 | ) | ||||||
Accounts payable and accrued liabilities |
(121 | ) | (433 | ) | |||||
Accrued claims payable |
(64 | ) | (970 | ) | |||||
Accrued reinsurance claims payable |
226 | 402 | |||||||
Income taxes payable |
2 | 4 | |||||||
Other liabilities |
| (2 | ) | ||||||
Net cash used in continuing operations |
(90 | ) | (1,150 | ) | |||||
Net cash used in discontinued operations |
| | |||||||
Net cash used in continuing and discontinued operations |
(90 | ) | (1,150 | ) | |||||
Cash flows from investing activities: |
|||||||||
Net proceeds from sale of property and equipment |
| 2 | |||||||
Payments received on note receivable |
1 | 1 | |||||||
Additions to property and equipment |
(80 | ) | (18 | ) | |||||
Net cash used in investing activities |
(79 | ) | (15 | ) | |||||
Cash flows from financing activities: |
|||||||||
Proceeds from issuance of Common Stock |
1 | | |||||||
Repayment of debt |
(6 | ) | (1 | ) | |||||
Net cash used in financing activities |
(5 | ) | (1 | ) | |||||
Net decrease in cash and cash equivalents |
(174 | ) | (1,166 | ) | |||||
Cash and cash equivalents at beginning of year |
3,590 | 5,340 | |||||||
Cash and cash equivalents at end of period |
$ | 3,416 | $ | 4,174 | |||||
See accompanying notes
5
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
Note 1 Summary of Significant Accounting Policies
The consolidated balance sheet as of August 31, 2003, and the related consolidated statements of operations and cash flows for the three months ended August 31, 2003 and 2002 are unaudited and have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. In the opinion of management, all adjustments necessary for a fair presentation of such financial statements have been included. Such adjustments consisted only of normal recurring items. The results of operations for the three months ended August 31, 2003 are not necessarily indicative of the results to be expected during the balance of the fiscal year.
The consolidated financial statements do not include all information and footnotes necessary for a complete presentation of financial position, results of operations and cash flows in conformity with accounting principles generally accepted in the United States of America. The balance sheet at May 31, 2003 has been derived from the audited financial statements at that date, but does not include all of the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statement presentation. Notes to consolidated financial statements included in Form 10-K for the year ended May 31, 2003 are on file with the Securities and Exchange Commission and provide additional disclosures and a further description of accounting policies.
The Companys financial statements are presented on the basis that it is a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The consolidated financial statements do not include any adjustments to reflect the possible future effects on the recovery and classification of assets or the amount and classification of liabilities that may result from the outcome of the uncertainties described in Note 2 Basis of Presentation.
The Companys managed care activities are performed under the terms of agreements with health maintenance organizations (HMOs), preferred provider organizations (PPOs), and other health plans or payers to provide contracted behavioral healthcare services to subscribing participants. Revenue under a substantial portion of these agreements is earned monthly based on the number of qualified participants regardless of services actually provided (generally referred to as capitation arrangements). Such agreements accounted for 87.7%, or $6.9 million, of revenue for the three months ended August 31, 2003 and 86.6%, or $7.2 million, of revenue for the three months ended August 31, 2002. The balance of the Companys revenues is earned on a fee-for-service basis and is recognized as services are rendered.
Restricted Cash
As of August 31, 2003 and May 31, 2003, non-current restricted accounts include $0.3 million of cash held in trust in connection with the Companys Directors and Officers liability insurance policy.
Accrued Claims Payable
The accrued claims payable liability represents the estimated ultimate net amounts owed for all behavioral healthcare services provided through the respective balance sheet dates, including estimated amounts for claims incurred but not yet reported (IBNR) to the Company. The unpaid claims liability is estimated using an actuarial paid completion factor methodology and other statistical analyses and is continually reviewed and adjusted, if necessary, to reflect any change in the estimated liability. These estimates are subject to the effects of trends in utilization and other factors. However, actual claims incurred could differ from the estimated claims payable amount reported as of August 31, 2003. Although considerable variability is inherent in such estimates, management believes that the unpaid claims liability is adequate.
Income Taxes
The Company calculates deferred taxes and related income tax expense using the liability method. This method determines deferred taxes by applying the current tax rate to net operating loss carryforwards and to the cumulative temporary differences between the recorded carrying amounts and the corresponding tax basis of assets and liabilities. A valuation allowance is established for deferred tax assets unless their realization is considered more likely than not. The Companys provision for income taxes is the sum of the change in the balance of deferred taxes between the beginning and the end of the period and income taxes currently payable or receivable.
6
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
Stock Options
In December 2002, the Financial Accounting Standards Board issued Statements of Financial Accounting Standards No. 148, Accounting for Stock-Based Compensation Transition and Disclosure, which amends the disclosure requirements of SFAS 123, Accounting for Stock-Based Compensation and provides alternative methods of transition for a voluntary change to the fair value method of accounting for stock-based employee compensation. As permitted by SFAS 148, the Company has elected to follow Accounting Principles Board Opinion No. 25, Accounting for Stock Issued to Employees (APB 25) and related interpretations in accounting for its employee stock options. Under APB 25, in the event that the exercise price of the Companys employee stock options is less than the market price of the underlying stock on the date of grant, compensation expense is recognized. No stock-based employee compensation cost is reflected in net income, as all options granted under the Companys employee stock options plans had an exercise price equal to the market value of the underlying common stock on the date of grant. The following table illustrates the effect on net loss and loss per share if the Company had applied the fair value recognition provisions of SFAS No. 123 to stock-based employee compensation.
| Quarter Ended August 31, | ||||||||||
| 2003 | 2002 | |||||||||
| (in thousands except for | ||||||||||
| per share information) | ||||||||||
Net loss, as reported |
$ | (325 | ) | $ | (33 | ) | ||||
Deduct: |
||||||||||
Total stock-based employee compensation expense determined
under fair value based method for all awards, net of related tax
effects |
(40 | ) | (9 | ) | ||||||
Pro forma net loss |
$ | (365 | ) | $ | (42 | ) | ||||
Loss per common share: |
||||||||||
Basic as reported |
$ | (0.08 | ) | $ | (0.01 | ) | ||||
Diluted as reported |
$ | (0.07 | ) | $ | (0.01 | ) | ||||
Basic pro forma |
$ | (0.09 | ) | $ | (0.01 | ) | ||||
Diluted pro forma |
$ | (0.08 | ) | $ | (0.01 | ) | ||||
7
COMPREHENSIVE CARE CORPORATION AND SUBSIDIARIES
Per Share data
In calculating basic earnings (loss) per share, net income (loss) is divided by the weighted average number of common shares outstanding for the period. Diluted earnings per share reflect the assumed exercise or conversion of all dilutive securities, such as options, warrants, and convertible debentures. No such exercise or conversion is assumed where the effect is antidilutive, such as when there is a net loss. The following table sets forth the computation of basic and diluted earnings (loss) per share in accordance with Statement No. 128, Earnings Per Share (amounts in thousands, except per share data):
| Three Months Ended | ||||||||||
| August 31, | ||||||||||
| 2003 | 2002 | |||||||||
Numerator: |
||||||||||
Numerator for diluted earnings (loss) per share from continuing operations |
$ | 62 | $ | (33 | ) | |||||
Loss from discontinued operations |
(387 | ) | | |||||||
Net loss attributable to common stockholders |
$ | (325 | ) | $ | (33 | ) | ||||
Denominator: |
||||||||||
Weighted average shares |
3,937 | 3,885 | ||||||||
Effect of dilutive securities: |
||||||||||
Employee stock options |
782 | | ||||||||
Warrants |
6 | | ||||||||
Denominator for diluted earnings (loss) per share-adjusted weighted
average shares after assumed conversions |
4,725 | 3,885 | ||||||||
Basic loss per share: |
||||||||||
Income (loss) from continuing operations |
$ | 0.02 | $ | (0.01 | ) | |||||
Loss from discontinued operations |
(0.10 | ) | | |||||||
Net loss |
$ | (0.08 | ) | $ | (0.01 | ) | ||||
Diluted loss per share: |
||||||||||
Income (loss) from continuing operations |
$ | 0.01 | $ | (0.01 | ) | |||||
Loss from discontinued operations |
(0.08 | ) | | |||||||
Net loss |
$ | (0.07 | ) | $ | (0.01 | ) | ||||
Authorized shares of common stock reserved for possible issuance for convertible debentures and stock options are as follows at August 31, 2003:
Convertible debentures |
9,044 | |||
Outstanding stock options |
1,105,724 | |||
Possible future issuance under stock option plans |
445,235 | |||